197 related articles for article (PubMed ID: 37066022)
1. Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time.
Rajan S; Zaccaria S; Cannon MV; Cam M; Gross AC; Raphael BJ; Roberts RD
Cancer Res Commun; 2023 Apr; 3(4):564-575. PubMed ID: 37066022
[TBL] [Abstract][Full Text] [Related]
2. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract][Full Text] [Related]
3. Genome-Informed Targeted Therapy for Osteosarcoma.
Sayles LC; Breese MR; Koehne AL; Leung SG; Lee AG; Liu HY; Spillinger A; Shah AT; Tanasa B; Straessler K; Hazard FK; Spunt SL; Marina N; Kim GE; Cho SJ; Avedian RS; Mohler DG; Kim MO; DuBois SG; Hawkins DS; Sweet-Cordero EA
Cancer Discov; 2019 Jan; 9(1):46-63. PubMed ID: 30266815
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
[TBL] [Abstract][Full Text] [Related]
5. Genomics and the Immune Landscape of Osteosarcoma.
Wu CC; Livingston JA
Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
[TBL] [Abstract][Full Text] [Related]
6. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
[TBL] [Abstract][Full Text] [Related]
7. [The clonal evolution of osteosarcomas].
Baumhoer D
Pathologe; 2016 Nov; 37(Suppl 2):163-168. PubMed ID: 27651058
[TBL] [Abstract][Full Text] [Related]
8. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns.
Luo S; Zhang Y; Jia Y; Zhang X
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12831. PubMed ID: 35767937
[TBL] [Abstract][Full Text] [Related]
10. Pervasive chromosomal instability and karyotype order in tumour evolution.
Watkins TBK; Lim EL; Petkovic M; Elizalde S; Birkbak NJ; Wilson GA; Moore DA; Grönroos E; Rowan A; Dewhurst SM; Demeulemeester J; Dentro SC; Horswell S; Au L; Haase K; Escudero M; Rosenthal R; Bakir MA; Xu H; Litchfield K; Lu WT; Mourikis TP; Dietzen M; Spain L; Cresswell GD; Biswas D; Lamy P; Nordentoft I; Harbst K; Castro-Giner F; Yates LR; Caramia F; Jaulin F; Vicier C; Tomlinson IPM; Brastianos PK; Cho RJ; Bastian BC; Dyrskjøt L; Jönsson GB; Savas P; Loi S; Campbell PJ; Andre F; Luscombe NM; Steeghs N; Tjan-Heijnen VCG; Szallasi Z; Turajlic S; Jamal-Hanjani M; Van Loo P; Bakhoum SF; Schwarz RF; McGranahan N; Swanton C
Nature; 2020 Nov; 587(7832):126-132. PubMed ID: 32879494
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability.
Raynaud F; Mina M; Tavernari D; Ciriello G
PLoS Genet; 2018 Sep; 14(9):e1007669. PubMed ID: 30212491
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
Schmidt MJ; Prabakar RK; Pike S; Yellapantula V; Peng CC; Kuhn P; Hicks J; Xu L; Berry JL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239954
[TBL] [Abstract][Full Text] [Related]
13. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.
Kovac M; Blattmann C; Ribi S; Smida J; Mueller NS; Engert F; Castro-Giner F; Weischenfeldt J; Kovacova M; Krieg A; Andreou D; Tunn PU; Dürr HR; Rechl H; Schaser KD; Melcher I; Burdach S; Kulozik A; Specht K; Heinimann K; Fulda S; Bielack S; Jundt G; Tomlinson I; Korbel JO; Nathrath M; Baumhoer D
Nat Commun; 2015 Dec; 6():8940. PubMed ID: 26632267
[TBL] [Abstract][Full Text] [Related]
15. The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies.
Kovac M; Ameline B; Ribi S; Kovacova M; Cross W; Barenboim M; Witt O; Bielack S; Krieg A; Hartmann W; Nathrath M; Baumhoer D
J Pathol; 2021 Aug; 254(5):556-566. PubMed ID: 33963544
[TBL] [Abstract][Full Text] [Related]
16. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
[TBL] [Abstract][Full Text] [Related]
18. The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.
Brady SW; Ma X; Bahrami A; Satas G; Wu G; Newman S; Rusch M; Putnam DK; Mulder HL; Yergeau DA; Edmonson MN; Easton J; Alexandrov LB; Chen X; Mardis ER; Wilson RK; Downing JR; Pappo AS; Raphael BJ; Dyer MA; Zhang J
Mol Cancer Res; 2019 Apr; 17(4):895-906. PubMed ID: 30651371
[TBL] [Abstract][Full Text] [Related]
19. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
[TBL] [Abstract][Full Text] [Related]
20. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
Schott C; Shah AT; Sweet-Cordero EA
Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
